119 related articles for article (PubMed ID: 28485477)
21. Diabetes mellitus is independently associated with adverse clinical outcome in soft tissue sarcoma patients.
Stelzl A; Aziz F; Riedl JM; Posch F; Smolle MA; Stojakovic T; Terbuch A; Pichler M; Bergovec M; Leithner A; Liegl-Atzwanger B; Stotz M; Gerger A; Sourij H; Szkandera J
Sci Rep; 2020 Jul; 10(1):12438. PubMed ID: 32709908
[TBL] [Abstract][Full Text] [Related]
22. Does serum albumin and creatinine predict survival of inpatient palliative care patients?
Aung A; Alqudihy S; Rybicki L; Platt A; Davis MP
Am J Hosp Palliat Care; 2014 Dec; 31(8):862-6. PubMed ID: 23990589
[TBL] [Abstract][Full Text] [Related]
23. Semi-Quantitative Calculations of Primary Tumor Metabolic Activity Using F-18 FDG PET/CT as a Predictor of Survival in 92 Patients With High-Grade Bone or Soft Tissue Sarcoma.
Andersen KF; Fuglo HM; Rasmussen SH; Petersen MM; Loft A
Medicine (Baltimore); 2015 Jul; 94(28):e1142. PubMed ID: 26181552
[TBL] [Abstract][Full Text] [Related]
24. Elevated preoperative neutrophil/lymphocyte ratio is associated with poor prognosis in soft-tissue sarcoma patients.
Szkandera J; Absenger G; Liegl-Atzwanger B; Pichler M; Stotz M; Samonigg H; Glehr M; Zacherl M; Stojakovic T; Gerger A; Leithner A
Br J Cancer; 2013 Apr; 108(8):1677-83. PubMed ID: 23558897
[TBL] [Abstract][Full Text] [Related]
25. Absence of progression, not extent of tumour shrinkage, defines prognosis in soft-tissue sarcoma - An analysis of the EORTC 62012 study of the EORTC STBSG.
Grünwald V; Litière S; Young R; Messiou C; Lia M; Wardelmann E; van der Graaf W; Gronchi A; Judson I;
Eur J Cancer; 2016 Sep; 64():44-51. PubMed ID: 27323349
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of Absolute Lymphocyte Count at Diagnosis and Mortality Among Patients With Localized Bone or Soft Tissue Sarcoma.
Brewster R; Purington N; Henry S; Wood D; Ganjoo K; Bui N
JAMA Netw Open; 2021 Mar; 4(3):e210845. PubMed ID: 33666664
[TBL] [Abstract][Full Text] [Related]
27. The efficacy of postoperative radiotherapy in localized primary soft tissue sarcoma treated with conservative surgery.
Zhao RP; Yu XL; Zhang Z; Jia LJ; Feng Y; Yang ZZ; Chen XX; Wang J; Ma SL; Guo XM
Radiat Oncol; 2016 Feb; 11():25. PubMed ID: 26911328
[TBL] [Abstract][Full Text] [Related]
28. Clinical significance of pretreatment serum C-reactive protein level in soft tissue sarcoma.
Nakamura T; Matsumine A; Matsubara T; Asanuma K; Uchida A; Sudo A
Cancer; 2012 Feb; 118(4):1055-61. PubMed ID: 21761398
[TBL] [Abstract][Full Text] [Related]
29. Prognostic serum markers in patients with high-grade upper tract urothelial carcinoma.
Sheth KR; Haddad AQ; Ashorobi OS; Meissner MA; Sagalowsky AI; Lotan Y; Margulis V
Urol Oncol; 2016 Sep; 34(9):418.e9-418.e16. PubMed ID: 27234379
[TBL] [Abstract][Full Text] [Related]
30. Prognostic factors of retroperitoneal soft tissue sarcomas: analysis of 132 cases.
Chen CQ; Yin L; Peng CH; Cai Y; Li YF; Zhao R; Zhou HJ; Li HW
Chin Med J (Engl); 2007 Jun; 120(12):1047-50. PubMed ID: 17637220
[TBL] [Abstract][Full Text] [Related]
31. Histologic Appearance After Preoperative Radiation Therapy for Soft Tissue Sarcoma: Assessment of the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group Response Score.
Schaefer IM; Hornick JL; Barysauskas CM; Raut CP; Patel SA; Royce TJ; Fletcher CDM; Baldini EH
Int J Radiat Oncol Biol Phys; 2017 Jun; 98(2):375-383. PubMed ID: 28463157
[TBL] [Abstract][Full Text] [Related]
32. Pre-treatment anemia is a poor prognostic factor in soft tissue sarcoma patients.
Szkandera J; Gerger A; Liegl-Atzwanger B; Stotz M; Samonigg H; Ploner F; Stojakovic T; Leithner A; Pichler M
PLoS One; 2014; 9(9):e107297. PubMed ID: 25207808
[TBL] [Abstract][Full Text] [Related]
33. Serum Biomarkers as Prognostic Factors for Metastatic Sarcoma.
Aggerholm-Pedersen N; Maretty-Kongstad K; Keller J; Safwat A
Clin Oncol (R Coll Radiol); 2019 Apr; 31(4):242-249. PubMed ID: 30744933
[TBL] [Abstract][Full Text] [Related]
34. Histopathological re-classification of extremity pleomorphic soft tissue sarcoma has clinical relevance.
Massi D; Beltrami G; Capanna R; Franchi A
Eur J Surg Oncol; 2004 Dec; 30(10):1131-6. PubMed ID: 15522563
[TBL] [Abstract][Full Text] [Related]
35. Uric acid levels in blood are associated with clinical outcome in soft-tissue sarcoma patients.
Szkandera J; Gerger A; Liegl-Atzwanger B; Stotz M; Samonigg H; Ploner F; Stojakovic T; Gary T; Leithner A; Pichler M
Clin Chem Lab Med; 2015 Feb; 53(3):493-7. PubMed ID: 25324451
[TBL] [Abstract][Full Text] [Related]
36. New perspectives for staging and prognosis in soft tissue sarcoma.
Lahat G; Tuvin D; Wei C; Anaya DA; Bekele BN; Lazar AJ; Pisters PW; Lev D; Pollock RE
Ann Surg Oncol; 2008 Oct; 15(10):2739-48. PubMed ID: 18521685
[TBL] [Abstract][Full Text] [Related]
37. Validation of Different Nutritional Assessment Tools in Predicting Prognosis of Patients with Soft Tissue Spindle-Cell Sarcomas.
Sasaki H; Nagano S; Komiya S; Taniguchi N; Setoguchi T
Nutrients; 2018 Jun; 10(6):. PubMed ID: 29899304
[TBL] [Abstract][Full Text] [Related]
38. Impact of margin status and local recurrence on soft-tissue sarcoma outcomes.
Potter BK; Hwang PF; Forsberg JA; Hampton CB; Graybill JC; Peoples GE; Stojadinovic A
J Bone Joint Surg Am; 2013 Oct; 95(20):e151. PubMed ID: 24132366
[TBL] [Abstract][Full Text] [Related]
39. An analysis of patient characteristics and clinical outcomes in primary pulmonary sarcoma.
Spraker MB; Bair E; Bair R; Connell PP; Mahmood U; Koshy M
J Thorac Oncol; 2013 Feb; 8(2):147-51. PubMed ID: 23263688
[TBL] [Abstract][Full Text] [Related]
40. Sampling modality influences the predictive value of grading in adult soft tissue extremity sarcomas.
Khoja H; Griffin A; Dickson B; Wunder J; Ferguson P; Howarth D; Kandel R
Arch Pathol Lab Med; 2013 Dec; 137(12):1774-9. PubMed ID: 24283858
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
